SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Market Valuation of Biotechnology Firms and Biotechnology R&D
16 references·2 citing·37 second hop
The Market Valuation of Biotechnology Firms and Biotechnology R&D (2001)The Market Valuation of Biotechnology Fir…Innovation in Large and Small Firms: An Empirical Analysis (2008)Innovation in Large and Small…Capitalization versus Expensing: Evidence on the Uncertainty of Future Earnings from Capital Expenditures versus R&D Outlays (2002)Capitalization versus Expensi…The Stock Market Valuation of Research and Development Expenditures (2001)The Stock Market Valuation of…Intangibles: Management, Measurement, and Reporting (2001)Intangibles: Management, Meas…Market Value and Patent Citations: A First Look (2000)Market Value and Patent Citat…Interorganizational Endorsements and the Performance of Entrepreneurial Ventures (1999)Interorganizational Endorseme…An empirical assessment of the residual income valuation model (1999)An empirical assessment of th…Relative valuation roles of equity book value and net income as a function of financial health (1998)Relative valuation roles of e…The capitalization, amortization, and value-relevance of R&D (1996)The capitalization, amortizat…Valuation and Clean Surplus Accounting for Operating and Financial Activities* (1995)Valuation and Clean Surplus A…Earnings, Book Values, and Dividends in Equity Valuation* (1995)Earnings, Book Values, and Di…The Management of Innovation (1994)The Management of InnovationIndustrial market structure and economic performance (1990)Industrial market structure a…Innovation, Market Structure, and Firm Size (1987)Innovation, Market Structure,…Risk, Return, and Equilibrium: Empirical Tests (1973)Risk, Return, and Equilibrium…Industrial Market Structure and Economic Performance. (1971)Industrial Market Structure a…Underwriter learning about unfamiliar firms: Evidence from the history of biotech IPOS (2006)Underwriter learning about un…The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs (2003)The Usefulness of Biotechnolo…The Strength of Weak Ties (1973)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)The Network Structure Of Social Capital (2000)Structural Holes and Good Ideas (2004)The dynamics of crowdfunding: An exploratory study (2013)Exchange and Power in Social Life (2017)The Cost of Capital, Corporation Finance and the Theory of Investment (1958)Dividend Policy, Growth, and the Valuation of Shares (1961)The Valuation of Uncertain Income Streams and the Pricing of Options (1976)Capital markets research in accounting (2001)Does Corporate Social Responsibility Affect the Cost of Capital? (2010)CAPITAL ASSET PRICES: A THEORY OF MARKET EQUILIBRIUM UNDER CONDITIONS OF RISK* (1964)The Behavior of Stock-Market Prices (1965)THE VALUATION OF RISK ASSETS AND THE SELECTION OF RISKY INVESTMENTS IN STOCK PORTFOLIOS AND CAPITAL BUDGETS**This paper is another in a series of interrelated theoretical and statistical studies of corporate financial and investment policies being made under grants from the Rockefeller Foundation, and more recently the Ford Foundation, to the Harvard Business School. The generous support for this work is most gratefully acknowledged. The author is also much indebted to his colleagues Professors Bishop, Christenson, Kahr, Raiffa, and (especially) Schlaifer, for extensive discussion and commentary on an earlier draft of this paper; but responsibility for any errors or imperfections remains strictly his own.[Professor Sharpe's paper, “Capital Asset Prices: A Theory of Market Equilibrium Under Conditions of Risk” (Journal of Finance, September 1964) appeared after this paper was in final form and on its way to the printers. My first section, which parallels the first half of his paper (with corresponding conclusions), sets the algebraic framework for sections II, III and VI, (which have no counterpart in his paper) and for section IV on the equilibrium prices of risk assets, concerning which our results differ significantly for reasons which will be explored elsewhere. Sharpe does not take up the capital budgeting problem developed in section V below.] (1975)On Persistence in Mutual Fund Performance (1997)Toward an Implied Cost of Capital (2001)Expected EPS and EPS Growth as Determinantsof Value (2005)The cost of capital, corporation finance and the theory of investment (2008)The Cross-Section of Expected Stock Returns (1992)Dynamic capabilities and strategic management (1997)Understanding earnings quality: A review of the proxies, their determinants and their consequences (2010)Corporate social responsibility and access to finance (2013)Common risk factors in the returns on stocks and bonds (1993)Does the stock market fully value intangibles? Employee satisfaction and equity prices (2011)Digesting Anomalies: An Investment Approach (2012)The other side of value: The gross profitability premium (2013)Collaboration Networks, Structural Holes, and Innovation: A Longitudinal Study (2000)The knowledge spillover theory of entrepreneurship (2008)Is innovation always beneficial? A meta-analysis of the relationship between innovation and performance in SMEs (2010)Stakeholder influence capacity and the variability of financial returns to corporate social responsibility (2007)Location, control and innovation in knowledge-intensive industries (2008)Knowledge Management in Theory and Practice (2013)Strategic networks (2000)Ecosystem as Structure (2016)Firm Resources and Sustained Competitive Advantage (1991)Clarifying the Entrepreneurial Orientation Construct and Linking It To Performance (1996)Firm resources and sustained competitive advantage (2004)
this work references cited by second hop

References

  • 1973Risk, Return, and Equilibrium: Empirical Tests14,248 cited
  • 1971Industrial Market Structure and Economic Performance.6,304 cited
  • 1995Earnings, Book Values, and Dividends in Equity Valuation*5,061 cited
  • 1999Interorganizational Endorsements and the Performance of Entrepreneurial Ventures2,787 cited
  • 1990Industrial market structure and economic performance2,607 cited
  • 1995Valuation and Clean Surplus Accounting for Operating and Financial Activities*2,224 cited
  • 2008Innovation in Large and Small Firms: An Empirical Analysis2,023 cited
  • 1996The capitalization, amortization, and value-relevance of R&D1,947 cited
  • 2001The Stock Market Valuation of Research and Development Expenditures1,871 cited
  • 2001Intangibles: Management, Measurement, and Reporting1,832 cited
  • 1994The Management of Innovation1,232 cited
  • 1987Innovation, Market Structure, and Firm Size1,124 cited
  • 2000Market Value and Patent Citations: A First Look1,095 cited
  • 1999An empirical assessment of the residual income valuation model918 cited
  • 1998Relative valuation roles of equity book value and net income as a function of financial health897 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2002Capitalization versus Expensing: Evidence on the Uncertainty of Future Earnings from Capital Expenditures versus R&D Outlays792 cited
  • Cited by

    • 2003The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs50 cited
    • 2006Underwriter learning about unfamiliar firms: Evidence from the history of biotech IPOS17 cited